Last updated: October 2, 2023
Sponsor: Karolinska University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Scar Tissue
Hyponatremia
Hepatic Fibrosis
Treatment
Structured advice on physical activity
Standard of Care advice on physical activity
Clinical Study ID
NCT05061576
2021-04454
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Liver cirrhosis diagnosed with previous clinical assessment and radiology (de-formedliver, noduli, varices, collaterals, splenomegaly >12 cm) or with biopsy (fibrosisgrade 4). ICD-code K70.3, K74.6.
- MELD < 25
- Understanding the Swedish language.
- Signed informed consent.
Exclusion
Exclusion Criteria:
- Performance status ≥3.
- Severe pain which prevents the patient to perform the physical activities, as judgedby the attending physician at time of discharge.
- Previously liver transplanted
- Unlikely to be compliant to follow-up (living in other parts of Sweden), as judged bythe attending physician at time of discharge.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Structured advice on physical activity
Phase:
Study Start date:
August 16, 2022
Estimated Completion Date:
December 31, 2026
Connect with a study center
Karolinska University Hospital
Stockholm, 14186
SwedenActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.